L-α-Phosphatidylcholine - ≥40%(enzymatic), from dried egg yolk, Type X-E , CAS No.8002-43-5

CAS: 8002-43-5 Cat. No.: L434223 Fórmula: C42H80NO8P Peso molecular: 758.06 Beilstein Registry Number: 5209585 Número CE: 232-307-2
Disponível para encomenda
GRAU & PUREZA ≥40%(enzymatic) from dried egg yolk, Type X-E
Synonyms
PC|PC(16:0/18:2(9Z,12Z))|[(2R)-3-hexadecanoyloxy-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate|1-palmitoyl-2-linoleoyl-phosphatidylcholine|PALMITOYL-LINOLEOYL PHOSPHATIDYLCHOLINE|Soy PC, L-alpha-phosphatidylcholine (Soy), chloroform|Lecithin, Refined|1-16:0-2-18:2-phosphatidylcholine|16:0-18:2-PC|1-palmitoyl-2-linoleoyl-GPC|1-Palmitoyl-2-linoleoyl-sn-glycero-3-phosphocholine|PC(16:0/18:2)|Phosphatidylserine Powder|16:0-18:2 PC, 1-palmitoyl-2-linoleoyl-sn-glycero-3-phosphocholine, powder|L-alpha-1-Palmitoyl-2-linoleoylphosphatidylcholine|1-Palmitoyl-2-linoleoyl-3-sn-glycerophosphatidylcholine|(2R)-3-(hexadecanoyloxy)-2-[(9Z,12Z)-octadeca-9,12-dienoyloxy]propyl 2-(trimethylammonio)ethyl phosphate|16:0-18:2 PC, 1-palmitoyl-2-linoleoyl-sn-glycero-3-phosphocholine, chloroform|1,2-Diacyl-sn-glycero-3-phosphocholine|Phosphatidylcholine(16:0/18:2)|PC(16:0/18:2omega6)|Soybean phosphatide|SOYBEAN PHOSPHOLIPIDS|phosphatidylcholine 16:0/18:2(9Z,12Z)|Soybean lecithin|(2-{[3-(hexadecanoyloxy)-2-[octadeca-9.12-dienoyloxy]propyl phosphono]oxy}ethyl)trimethylazanium|1-palmitoyl-2-linoleoyl-GPC (16:0/18:2)|GPC(16:0/18:2)|LECITHIN|3,5,8-Trioxa-4-phosphahexacosa-17,20-dien-1-aminium, 4-hydroxy-N,N,N-trimethyl-9-oxo-7-(((1-oxohexadecyl)oxy)methyl)-, inner salt, 4-oxide, (7R,17Z,20Z)-|Soy PC, L-alpha-phosphatidylcholine (Soy), powder|PC(16:0/18:2n6)|Phosphatidylcholine(16:0/18:2w6)|GPCho(16:0/18:2omega6)|L-.ALPHA.-1-PALMITOYL-2-LINOLEOYLPHOSPHATIDYLCHOLINE|GPCho(16:0/18:2)|1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine|(2R)-3-(hexadecanoyloxy)-2-[(9Z,12Z)-octadeca-9,12-dienoyloxy]propyl 2-(trimethylazaniumyl)ethyl phosphate|Phosphatidylcholine(16:0/18:2omega6)|PC 34:2|1-Palmitoyl-2-linoleoyl-sn-glycerophosphatidylcholine|1-Palmitoyl-2-linoleoyl-sn-glycero-phosphatidylcholine|Soybean phospholipid
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
★
Tamanho
Alemanha (EU)
USA*
Preço
Qtd
1g
L434223-1g
Sob encomenda · 8–12 semanas
69,33€
5g
L434223-5g
Sob encomenda · 8–12 semanas
156,11€
10g
L434223-10g
—
1 Em stock
253,29€
Enter a quantity for the sizes you want to add.

Especificações

Sinónimos
PC | PC(16:0/18:2(9Z,12Z)) | [(2R)-3-hexadecanoyloxy-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate | 1-palmitoyl-2-linoleoyl-phosphatidylcholine | PALMITOYL-LINOLEOYL PHOSPHATIDYLCHOLINE | Soy PC, L-alpha-phosphatidylcholine (Soy), chloroform | Lecithin, Refined | 1-16:0-2-18:2-phosphatidylcholine | 16 Show more
Especificações e pureza
≥40%(enzymatic), from dried egg yolk, Type X-E
Mecanismos bioquímicos e fisiológicos
A major structural phospholipid in brain, comprising approx. 15% of total lipid; primarily localized to gray matter.
Condições de armazenamento de armazenamento
Store at -20°C
Enviado em
Ice chest + Ice pads
Este produto requer transporte de cadeia fria. Serviços terrestres e outros serviços econômicos não estão disponíveis.
Pureza
≥40%(enzymatic)
Nomes e identificadores
Pubchem Sid
Pubchem Sid Url
https://pubchem.ncbi.nlm.nih.gov/substance/504763513
SMILES
[P](=O)([O-])(OC[C@H](OC(=O)CCCCCCC\C=C/C\C=C/CCCCC)COC(=O)CCCCCCCCCCCCCCC)OCC[N+](C)(C)C
IUPAC Name
[(2R)-3-hexadecanoyloxy-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
InChIKey
JLPULHDHAOZNQI-ZTIMHPMXSA-N
InChI
1S/C42H80NO8P/c1-6-8-10-12-14-16-18-20-21-23-25-27-29-31-33-35-42(45)51-40(39-50-52(46,47)49-37-36-43(3,4)5)38-48-41(44)34-32-30-28-26-24-22-19-17-15-13-11-9-7-2/h14,16,20-21,40H,6-13,15,17-19,22-39H2,1-5H3/b16-14-,21-20-/t40-/m1/s1
SMILES isoméricas
CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCC/C=C\C/C=C\CCCCC
WGK Alemanha
1
RTECS
OG7565000
CAS alternativo
55128-59-1
Peso molecular
758.06
Beilstein
5209585
Reaxys
11330961
Reaxys-RN_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=11330961&ln=

Dados avançados

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassLipids and lipid-like molecules
ClasseGlycerophospholipids
SubclassGlycerophosphocholines
Intermediate Tree Nodes Not available
Direct ParentPhosphatidylcholines
Alternative Parents Phosphocholines  Fatty acid esters  Dialkyl phosphates  Dicarboxylic acids and derivatives  Tetraalkylammonium salts  Carboxylic acid esters  Organopnictogen compounds  Organic salts  Organic oxides  Hydrocarbon derivatives  Carbonyl compounds  Amines  
Molecular FrameworkAliphatic acyclic compounds
Substituents Diacylglycero-3-phosphocholine - Phosphocholine - Fatty acid ester - Dialkyl phosphate - Dicarboxylic acid or derivatives - Organic phosphoric acid derivative - Phosphoric acid ester - Alkyl phosphate - Fatty acyl - Quaternary ammonium salt - Tetraalkylammonium salt - Carboxylic acid ester - Carboxylic acid derivative - Organic oxygen compound - Organic nitrogen compound - Carbonyl group - Organooxygen compound - Organonitrogen compound - Organic oxide - Organopnictogen compound - Amine - Organic salt - Hydrocarbon derivative - Aliphatic acyclic compound
DescriçãoThis compound belongs to the class of organic compounds known as phosphatidylcholines. These are glycerophosphocholines in which the two free -OH are attached to one fatty acid each through an ester linkage.
External Descriptors Diacylglycerophosphocholines
Certificados(CoA,COO,BSE/TSE e Mapa de Análise)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

11 results found

Lot NumberCertificate TypeDataItem
H2318514H2318514Certificate of AnalysisJun 08, 2026 L434223
H2318630H2318630Certificate of AnalysisJun 08, 2026 L434223
I2601751I2601751Certificate of AnalysisApr 03, 2026 L434223
B2605024B2605024Certificate of AnalysisJun 14, 2025 L434223
F2523433F2523433Certificate of AnalysisJun 14, 2025 L434223
F2523623F2523623Certificate of AnalysisJun 14, 2025 L434223
F2523624F2523624Certificate of AnalysisJun 14, 2025 L434223
H2318512H2318512Certificate of AnalysisAug 02, 2023 L434223
H2318513H2318513Certificate of AnalysisAug 02, 2023 L434223
H2318628H2318628Certificate of AnalysisAug 02, 2023 L434223
H2318629H2318629Certificate of AnalysisAug 02, 2023 L434223
Propriedades químicas e físicas
Peso molecular758.1
XLogP312.900
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count8
Rotatable Bond Count40
Exact Mass757.562 Da
Monoisotopic Mass757.562 Da
Topological Polar Surface Area111.000 Ų
Heavy Atom Count52
Formal Charge0
Complexity940.000
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count2
Undefined Bond Stereocenter Count0
The total count of all stereochemical bonds2
Covalently-Bonded Unit Count1
Segurança e perigos (GHS)
WGK Alemanha
1
RTECS
OG7565000
Reaxys
11330961
Reaxys-RN_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=11330961&ln=
FAQs e artigos
Liposome Panorama Guide: Definition, Structural Mechanisms, Applications, and Selection Workflow (Including Products Table 1–Table 3)
Lecithin: Technical Characteristics, Preparation Processes, and Research Progress in Applications
Procyanidins: Structural Features and Key Points for Research and Application
Whey Protein: Composition Profile, Manufacturing Routes, and Key Product-Type Essentials
Functional Properties, Application Scenarios, and Manufacturing Processes of Maltotetraose (G4): A Review
Glutaraldehyde-mediated Microbial Inactivation: Chemical Mechanisms, Determinants, and Key Validation Considerations
Review of the Structural Characteristics, Biological Functions, and Application Advances of Lycopene
Functional Framework of Starch Metabolism-Related Enzymes in Food Science Research and Mechanistic Analysis of Quality Regulation
Mechanistic Analysis of Topical Glutathione in Skincare: Cellular Redox Regulation, Skin Delivery Challenges, and SLN-Based Delivery Strategies
Choline Metabolism and Detection Methods: Pathway Analysis of Choline, Phosphatidylcholine, Betaine, Acetylcholine, and TMAO
Antioxidant Mechanisms, Stability, and Delivery Strategies of Resveratrol in Skincare Research
Antioxidant Mechanisms of Ferulic Acid in Skincare, Vitamin C/E Synergy, and Stable Delivery Applications
Skin Anti-Aging Mechanisms of Carnosine and Decarboxy Carnosine: Active Carbonyl Scavenging, Oxidative-Stress Buffering, and Inhibition of Collagen Glycation Cross-Linking
The Moisturizing and Low-Moisture Protective Mechanisms of Trehalose: From Its α,α-1,1 Structure and Hydration Dynamics to In Vitro Skin Barrier Research
Protective and Potential Reparative Mechanisms of Prinsepia utilis Seed Oil on the Skin Barrier: Fatty Acid Composition, Epidermal Lipid Metabolism, and Research Evidence
UVA Absorption Mechanism of Avobenzone: Keto–Enol Tautomerism, Photochemical Instability, and Formulation Photostabilization Strategies
Mechanism of Action of Tranexamic Acid in Pigmentation Care: From the Plasmin System to Regulation of Inflammation-Driven Pro-Melanogenic Signaling
How Palmitoyl Pentapeptide-4 Acts on the Skin: From the KTTKS Sequence and Skin Delivery to Collagen Matrix Responses
How Cyclization Changes Peptide Behavior: Conformational Preorganization, Skin Delivery, and Integrin Binding, Using Cyclopeptide-5 as an Example
The Logic of Biomimetic Peptide Action in Skin: Sequence and Conformation, Skin Delivery, Stability, and Target Matching
How Does Collagen Tripeptide Act on the Skin: Stratum Corneum Delivery, Matrix Protection, and Regulation of Collagen Homeostasis
Potential Mechanisms of p-Cymene in Problem-Prone Skin: Membrane Perturbation, Inflammatory Signaling Modulation, and Localized Delivery
How Coenzyme Q10 Acts on the Skin: Mitochondrial Electron Transfer, Antioxidant Protection of Membrane Lipids, and Lipid-Carrier Delivery
The Combination Logic of Palmitoyl Tripeptide-1 and Palmitoyl Pentapeptide-4: Skin Delivery, Matrix Signaling, and Regulation of Collagen Homeostasis
How Arbutin Regulates Melanin Production: α/β Anomeric Configuration and Tyrosinase Action
Niacinamide Brightening Mechanisms and Formulation Design: Melanosome Transfer, pH Regulation, and Combination Strategies
Why Do Skincare Oligopeptides Have Different Effects? — Molecular Structure, Skin Delivery, and Mechanisms of Action
Citations of This Product
Calculadoras de soluções
Revisões

Avaliações dos Clientes

Application Protocols

Item-specific, validated protocols are not provided in the Product Data. Below are general, literature-style procedures to guide use; adjust to your system.

  • SUV preparation by probe sonication (general)

    • Dissolve PC in CHCl3/MeOH, cast a thin film, dry thoroughly.
    • Hydrate with HEPES-buffered saline to desired concentration (e.g., 5–20 mg/mL) above effective Tm; vortex to form MLVs.
    • Sonicate with a probe in pulse mode (e.g., 10 s on/20 s off, total 5–15 min) in an ice bath until the suspension is opalescent/clear. Remove titanium particulates by brief centrifugation.
  • LUV preparation by extrusion (general)

    • Prepare MLVs as above; pre-warm an extruder block.
    • Pass the dispersion through 0.4 µm → 0.2 µm → 0.1 µm membranes, ≥10 passes each. Verify size by DLS (target ~80–120 nm for 0.1 µm filter).
  • Ethanol injection (general)

    • Dissolve PC at 10 mg/mL in ethanol, filter (0.22 µm PTFE) if needed.
    • Inject into 10–20 volumes of stirred, warmed buffer; continue stirring 30–60 min; remove ethanol by dialysis.

Note: These are general guidelines for research use only. Optimize parameters (lipid concentration, temperature, cycles) for your formulation and instrumentation.

Biological Roles

(General literature context; no clinical claims)

  • Membrane architecture

    • Phosphatidylcholine is a major zwitterionic phospholipid in eukaryotic membranes, typically enriched in the outer leaflet of the plasma membrane and abundant in ER/Golgi membranes. It contributes to bilayer thickness, fluidity, and lateral organization.
  • Metabolic pathways

    • Synthesized via the Kennedy pathway (CDP-choline route) and via methylation of phosphatidylethanolamine (PE) in certain tissues/organelles.
    • Interconverts with signaling lipids: PLC yields DAG (activates PKC), PLD yields PA (signaling and biosynthetic intermediate), PLA1/2 yields lysophosphatidylcholine (LPC), a bioactive lysolipid.
  • Biophysical properties

    • Zwitterionic headgroup promotes neutral surface charge near physiological pH; mixed acyl chains modulate gel–fluid transitions and membrane curvature elasticity.
    • Interacts with cholesterol to modulate order and raft-like domain formation (composition dependent).
  • Functional relevance in research

    • Serves as a “background” matrix lipid in proteoliposomes to reduce non-specific electrostatic effects.
    • Used to study lipid asymmetry, scramblase/flippase activity, and protein–lipid specificity by substituting defined PC species (e.g., 16:0/18:1-PC) in place of mixtures.
  • Choline reservoir

    • The phosphocholine headgroup is a source of choline for acetylcholine and methyl donors through cellular metabolism (pathway studies only).
Buffer Applications

Phosphatidylcholine is not a buffering agent. However, buffer choice is critical for preparing stable PC dispersions and liposomes.

  • Common hydration buffers (literature/general)

    • HEPES-buffered saline (HBS): 10–20 mM HEPES, 150 mM NaCl, pH 7.2–7.6.
    • PBS: 10 mM phosphate, 137 mM NaCl, 2.7 mM KCl, pH ~7.4.
    • Tris-buffered saline (TBS): 10–50 mM Tris, 150 mM NaCl, pH 7.4–8.0 (avoid with some aldehyde chemistries).
    • For chelator-sensitive proteins, use 0.5–1 mM EDTA to suppress metal-catalyzed oxidation if compatible.
  • Practical tips

    • Filter-sterilize buffers (0.22 µm) and degas before hydration to improve vesicle quality and stability.
    • Adjust ionic strength/osmolarity to match encapsulants (e.g., sugars, salts) to prevent vesicle swelling/shrinkage.
    • Hydration temperature: choose at or above the effective Tm of the PC mixture; for unsaturated natural PCs, ambient to 40–50 °C is often sufficient (literature guidance).
  • Additives

    • Cholesterol (10–40 mol%) can tune membrane order and permeability.
    • Antioxidants (e.g., α-tocopherol) may be used in organic phase during film formation if compatible with downstream assays (not supplied unless stated).
Green Alternatives

While L-α-Phosphatidylcholine itself is a biogenic material, its handling often involves chlorinated solvents. Greener workflows can reduce environmental impact without sacrificing performance.

  • Solvent/workflow comparison (literature/general)

| Use case | Conventional choice | Greener alternative | Trade-offs | |---|---|---|---| | Thin-film dissolution | Chloroform:methanol (2:1) | Ethanol or isopropanol (absolute) | Lower solubility; may require warming; possible residual solvent unless dialyzed. | Liposome formation | Organic film hydration | Ethanol injection or microfluidic solvent exchange | Simpler, avoids chlorinated solvents; may yield broader size distributions unless extruded. | Cleaning glassware | Dichloromethane/hexane | Ethanol, isopropanol, acetone | Might need longer soaking; ensure complete drying. | Antioxidant strategy | BHT/toluene storage | Inert gas blanketing, amber vials, cold chain | Avoids additive contamination; requires rigorous technique.

  • Practical guidance

    • Use high-proof ethanol for dissolution and injection into warm buffer with vigorous mixing; follow with dialysis or diafiltration to remove ethanol.
    • Adopt microfluidic mixing devices for size-controlled vesicles using ethanol/isopropanol stocks.
    • Minimize waste by scaling solutions to immediate needs and storing bulk lipid as dry films under inert atmosphere.
  • Notes

    • Confirm compatibility of greener solvents with downstream assays (e.g., residual ethanol effects on proteins or cells in research models).
    • Always align with institutional green chemistry policies and waste regulations.
Pharmaceutical Uses

(Formulation/excipient context only; no therapeutic claims)

  • Roles in dosage forms (literature/general)

    • Liposomal excipient: primary bilayer former for liposomal dispersions used in research-stage formulations and process development.
    • Emulsifier/surfactant: aids oil-in-water emulsions and nanoemulsions; stabilizes dispersions via interfacial film formation.
    • Wetting/solubilization aid: enhances dispersion of hydrophobic actives in preclinical formulations.
  • Compendial considerations

    • “Lecithin” is described in major pharmacopeias (e.g., USP–NF, Ph. Eur.) with tests for identity, peroxide/acid values, solvent residue, and composition. Specific compliance for this item is Not specified for this item; refer to CoA/Spec Sheet.
  • Process notes

    • Source and acyl profile influence oxidation stability and Tm; storage and inert handling are crucial for consistent CQAs (particle size, PDI, zeta potential).
    • Residual solvents from film-casting need control (e.g., vacuum drying, nitrogen sparging) and verification by GC where applicable.
    • Sterile filtration (0.22 µm) is generally unsuitable for MLV/LUV dispersions; sterile manufacture may require aseptic processing and terminal sterilization strategies compatible with lipid integrity (e.g., gamma is often unsuitable for unsaturated PCs).
  • Regulatory awareness

    • For translational work, document source, allergen status (e.g., soy, egg), and absence/presence of antioxidants; maintain full batch traceability.
Physical Properties
  • Item-specific specifications

    • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
    • Grade/Purity: Not specified for this item; refer to CoA/Spec Sheet.
    • Molecular Weight: Not specified for this item; refer to CoA/Spec Sheet. (Note: natural PC is a distribution of MWs depending on acyl chains.)
  • General/literature properties for phosphatidylcholines (mixtures such as egg/soy PC)

    • Physical state: waxy solid to semi-solid; amphiphilic; forms multilamellar dispersions in water.
    • Solubility: readily soluble in chloroform, dichloromethane, and chloroform:methanol (2:1 v/v); moderately soluble in methanol and ethanol; practically insoluble in water but dispersible into bilayers/vesicles upon hydration and agitation.
    • Critical aggregation: forms lamellar phases and liposomes; no single CMC (non-micellar bilayer former); phase behavior depends on acyl composition and temperature.
    • Phase transition temperature (Tm): composition-dependent; unsaturated natural PCs typically exhibit low Tm (often below room temperature), while more saturated PCs show higher Tm (literature, varies widely by species).
    • pKa: phosphate is strongly acidic and largely ionized near neutral pH; choline is permanently cationic (quaternary ammonium); net zwitterionic near pH 2–8 (literature, qualitative).
    • Density/refractive index/logP: strongly composition- and solvent-dependent; not meaningful as single values for mixtures.
  • Practical notes

    • Forms clear solutions in chloroform; thin films cast from CHCl3/MeOH are standard for liposome preparation.
    • Oxidation of unsaturated chains can change physical properties; handle under inert atmosphere when possible.
Quality and Grades
  • Item-specific

    • Grade/Purity: Not specified for this item; refer to CoA/Spec Sheet.
    • Stabilizers/antioxidants: Not specified for this item; refer to CoA/Spec Sheet.
  • Interpreting grades for phosphatidylcholines (general guidance)

    • Natural-source lecithin vs highly purified PC: Natural lecithin may contain mixtures of PCs with other phospholipids (PE, PI) and neutral lipids. “High-purity PC” or “≥XX% PC” indicates enrichment of phosphatidylcholine species; exact assay method (e.g., HPLC, 31P NMR) should be consulted on the CoA.
    • Chromatography/lipidomics grade: Emphasizes low non-volatile residue and minimized oxidation products; often packaged under inert gas and light-protected.
    • Biochemical grade: Focus on functional performance in liposome formation and membrane protein reconstitution (e.g., clarity, vesicle size reproducibility), low peroxide/acid values.
  • What to verify on the CoA (recommended)

    • Identity/assay method (TLC, HPLC, 31P NMR), water content, acid value, peroxide value, fatty acyl profile (if available), residual solvent levels, microbial limits for aqueous dispersions (if applicable).
  • Practical implications

    • Stabilizers (e.g., BHT, tocopherol) can influence sensitive assays and oxidation kinetics; confirm presence/absence before use in sensitive biophysical or enzymology experiments.
    • Batch-to-batch acyl composition affects Tm and bilayer mechanics; for reproducibility, secure sufficient single-lot material or specify synthetic defined PCs when critical.
Reaction and Applications
  • Core research applications (literature/general)

    • Model membranes: formation of multilamellar (MLV), large unilamellar (LUV), and small unilamellar vesicles (SUV) for biophysical studies (phase behavior, diffusion, protein–lipid interactions).
    • Liposome technology: encapsulation of hydrophilic cargo (aqueous core) and hydrophobic cargo (bilayer); basis for extrusion-, microfluidic-, and ethanol-injection–derived vesicles.
    • Membrane protein reconstitution: assembly of proteoliposomes for transporters, channels, and receptors; often combined with cholesterol and other lipids to tune fluidity and packing.
    • Surface science: Langmuir–Blodgett/Langmuir–Schaefer deposition to create supported bilayers and monolayers.
    • Standards and reference materials: qualitative standards for TLC/31P NMR; matrix in MALDI of hydrophobic analytes (method-dependent).
  • Chemical/enzymatic transformations (literature)

    • Phospholipase A2 (PLA2): hydrolyzes sn‑2 acyl ester → lysophosphatidylcholine (LPC) + free fatty acid.
    • Phospholipase A1 (PLA1): hydrolyzes sn‑1 acyl ester → LPC.
    • Phospholipase C (PLC): cleaves phosphodiester → diacylglycerol (DAG) + phosphocholine.
    • Phospholipase D (PLD): produces phosphatidic acid (PA) + choline; transphosphatidylation possible with primary alcohols.
    • Chemical hydrogenation/epoxidation: modify unsaturated chains to tune Tm and oxidative stability (applies to unsaturated PCs).
  • Practical notes

    • For thin-film hydration, remove residual solvents thoroughly (vacuum ≥2 h) to avoid bilayer defects.
    • Include antioxidants and chelators only if compatible; trace metals and peroxides accelerate oxidation.
    • For extrusion, pre-heat above the mixture’s effective Tm; use 0.1–0.4 µm polycarbonate membranes for LUVs; multiple passes improve monodispersity.
Reaction Conditions

General working conditions for common laboratory uses of phosphatidylcholine (literature; adapt to your SOPs):

  • Thin-film hydration and liposome formation

    • Dissolve PC in CHCl3/MeOH (2:1). Evaporate under rotary vacuum to a thin film. Dry under high vacuum ≥2 h.
    • Hydrate with pre-warmed buffer (e.g., HEPES or PBS) at a temperature at/above the effective Tm of the mixture (often ambient to 40–50 °C for unsaturated natural PCs). Vortex/agitate to yield MLVs.
    • Size reduction: probe sonication on ice (bursts with cooling) for SUVs; or extrude MLVs through 0.4 → 0.2 → 0.1 µm polycarbonate membranes (≥10 passes) for LUVs with narrow PDI.
  • Ethanol injection

    • Prepare PC in absolute ethanol (5–20 mg/mL). Inject slowly into vigorously stirred warmed buffer (volume ratio ethanol:buffer typically 1:10–1:20). Remove residual ethanol by dialysis or diafiltration.
  • Enzymatic conversions

    • PLA2 assays often require Ca2+ (e.g., 1–10 mM) and mixed micelle or vesicle substrates; temperature 25–37 °C; monitor release of fatty acid or LPC by HPLC/LC–MS.
    • PLC/PLD reactions conducted in buffered aqueous/organic biphasic or vesicle systems; include appropriate cofactors and detergents as per enzyme source.
  • Oxidation control

    • Work under nitrogen/argon; include metal chelators if compatible; avoid prolonged light exposure. Store intermediate films at −20 °C under inert gas.
  • Analytical QC

    • Track phosphorus content (e.g., Bartlett assay) to quantify total lipid; verify vesicle size by DLS; assess oxidation by peroxide value or LC–MS for hydroperoxides.
Safety and Handling
  • GHS/SDS status (item-specific)

    • Signal Word: Not specified for this item; refer to SDS.
    • H-Statements: Not specified for this item; refer to SDS.
    • GHS Classification/Pictograms: Not specified for this item; refer to SDS.
  • Storage and transport (item-specific)

    • Storage Conditions: Store at −20 °C.
    • Shipped In: Ice chest + ice pads.
  • General safety considerations (literature/best practice)

    • Low volatility, non-flammable solid; dust formation is typically minimal for waxy material.
    • Potential hazards: peroxidation of unsaturated fatty acyl chains (rancidity) upon exposure to air/light; hydrolysis of ester bonds under strong acid/base; microbial growth in aqueous dispersions if not sterile.
    • Incompatibilities: strong oxidizers (risk of lipid oxidation), strong acids/bases (hydrolysis), prolonged exposure to light/air (oxidation).
    • Recommended PPE: lab coat, safety glasses, nitrile gloves; use in a clean area or fume hood when handling organic solvents (e.g., chloroform, methanol) for dissolution.
  • First-aid overview (consult SDS for authoritative guidance)

    • Inhalation: unlikely hazard; move to fresh air if aerosol generated.
    • Skin/eye contact: wash with soap/water; rinse eyes cautiously with water for several minutes; seek medical advice if irritation persists.
    • Ingestion: rinse mouth; do not induce vomiting; seek medical advice.
  • Handling tips

    • Work quickly with minimal air exposure; purge vials with inert gas after use.
    • For aqueous dispersions, prepare aseptically and store cold; add antioxidants or chelators only if compatible and justified by the protocol (not supplied unless stated).
Solvent Selection

L-α-Phosphatidylcholine is amphiphilic and best handled in chlorinated/aromatic alcohol solvent systems or as aqueous bilayer dispersions.

  • Polarity/miscibility (literature)

    • Highly soluble: chloroform, dichloromethane, chloroform:methanol (2:1 v/v), chloroform:isopropanol, toluene with alcohol cosolvent.
    • Moderately soluble: methanol, ethanol, isopropanol (often needs warming or sonication).
    • Water: insoluble as monomers; forms bilayers/vesicles upon hydration and agitation.
  • Typical use scenarios

    • Thin-film hydration: dissolve PC in CHCl3/MeOH, evaporate to a thin film, evacuate, then hydrate with buffer; suitable for MLVs → extrusion/sonication to LUVs/SUVs.
    • Ethanol injection/solvent exchange: dissolve PC in ethanol or isopropanol and inject into warm buffer for rapid vesicle formation (solvent removable by dialysis).
    • Detergent-assisted reconstitution: solubilize membrane proteins with mild detergents and back-dialyze with PC present to form proteoliposomes.
  • Choosing among options

    • CHCl3/MeOH: best for complete dissolution and clean film casting; requires fume hood and careful solvent removal.
    • Ethanol/isopropanol: greener and simpler; may leave residual solvent and give broader size distributions without extrusion.
    • Pure aqueous: only for hydration of pre-formed films or powders; apply temperatures above the lipid mixture’s effective Tm and vigorous mixing.
  • Practical tips

    • Degas and dry solvents; use amber glassware; purge with nitrogen/argon to limit oxidation.
    • For analytical prep (e.g., lipidomics), use LC-MS–compatible solvents and minimize plastic contact.
Structure and Identity

L-α-Phosphatidylcholine (commonly referred to as lecithin/PC) is a glycerophospholipid class material comprising mixtures of molecular species differing in fatty acyl chains.

  • Item-specific (Product Data)

    • SKU: L434223
    • Product Name: L-α-Phosphatidylcholine
    • CAS: 8002-43-5 (lecithins; mixture)
    • PubChem CID: 5287971 (lecithin/PC, general class entry)
    • InChIKey: 163683 (as provided)
    • SMILES: Not specified for this item; refer to CoA/Spec Sheet.
    • Molecular Formula: Not specified for this item; refer to CoA/Spec Sheet.
    • Molecular Weight: Not specified for this item; refer to CoA/Spec Sheet.
  • Structural description (general, literature)

    • Core scaffold: sn‑glycerol backbone esterified at sn‑1 and sn‑2 with long-chain fatty acids (C14–C22 commonly), and at sn‑3 with a phosphate linked to a choline headgroup (–O–PO2−–O–CH2CH2–N+(CH3)3).
    • Functional groups: two ester linkages (acyl esters), phosphate diester, quaternary ammonium (permanently cationic), multiple aliphatic chains (saturated/unsaturated).
    • Stereochemistry: natural L-α configuration at glycerol (sn-3 phosphodiester in the α orientation); acyl chains may be positioned at sn‑1/sn‑2 with typical preference for saturated at sn‑1 and unsaturated at sn‑2 (mixture-dependent).
    • Molecular heterogeneity: Being a natural-source mixture, individual species vary in chain length/unsaturation (e.g., 16:0/18:1 PC, 18:0/18:2 PC, etc.).
  • 2D structure in words (general)

    • A three-carbon glycerol “T” shape: two downward arms each bearing a fatty acyl ester (hydrophobic tails) and the upward arm bearing a phosphodiester linked to choline (polar head).
Synthetic Utility

Although L-α-Phosphatidylcholine is primarily used as a functional material rather than a reagent, it has defined synthetic and biocatalytic utility (literature/general):

  • As a substrate

    • Enzymatic generation of derivative lipids: PLA1/PLA2 → lysophosphatidylcholine; PLC → diacylglycerol; PLD → phosphatidic acid or transphosphatidylated PCs (with primary alcohols).
    • Chemical acyl exchange: convert LPC back to PC with defined acyl donors (e.g., activated fatty acids) to tailor acyl composition.
  • As a reactant/medium

    • Supramolecular catalysis: bilayers/microsomes can modulate reaction rates/selectivity of interfacial reactions.
    • Carrier matrix for phase-transfer or interfacial polymerizations in compartmentalized systems (liposome-templated syntheses).
  • Analytical chemistry

    • Internal standards/matrices in TLC/31P NMR to assess phospholipid content and purity of lipid mixtures.
  • Retrosynthetic perspective

    • PC serves as a convergent product from glycerol, two fatty acids, phosphate, and choline; manipulating each fragment (acyl chains, headgroup) allows systematic tuning of membrane properties in designed lipid libraries.
  • Practical considerations

    • Because this product is a mixture, exact stoichiometry in synthetic transformations is best expressed in mol% relative to total phosphorus (31P quantitation) or total lipid weight assuming an average MW derived from fatty acid profile (from CoA/lipidomics analysis).
Target Specificity

Not applicable. This product is a lipid mixture, not a biological probe or antibody. No target specificity information is provided in the Product Data.

Perguntas frequentes

What is the purity of this product, and how is it determined?
This product is supplied at ≥40% purity, determined by enzymatic assay. Lot-specific values are stated on the Certificate of Analysis.
How should this product be stored?
Store at ?20 °C. Freezer storage is required to maintain the specified shelf life.
How is this product shipped?
This product ships in an insulated container with ice pads. Unpack on arrival and transfer it to the storage condition stated above.
What are the CAS number, molecular formula and molecular weight?
The CAS Number is 8002-43-5, the molecular formula is C42H80NO8P, and the molecular weight is 758.06 g/mol. InChIKey JLPULHDHAOZNQI-ZTIMHPMXSA-N.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.

Deseja que lhe enviemos uma mensagem quando tivermos descontos disponíveis?

Lembrar-me mais tarde

Obrigado! Por favor, verifique a sua caixa de entrada de e-mail para confirmar.

Ops! As notificações estão desativadas.